Genomic Health, BioArray Solutions, The Regents of the University of Michigan | GenomeWeb

Genomic Health of Redwood City, Calif., has received US Patent No. 7,056,674, "Prediction of likelihood of cancer recurrence." The patent claims gene sets that can be expressed and used in the diagnosis and/or prognosis of cancer, particularly breast cancer, specifically with respect to disease-free survival. The patent also describes the use of archived paraffin-embedded biopsy material for assay of all markers in the set, and specifies oligonucleotide sequences that can be used for the gene sets in the test.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.